Patients and individuals in need of world-class healthcare services from Cebu and its nearby provinces now have improved access to top-notch medical facilities following the opening of Visayas Medical Hospital (VMH) Laboratory on April 3, 2024.
AppleOne Medical Group (AMG), the healthcare arm of the AppleOne Group of companies which owns the Visayas Medical Hospital, led the ribbon-cutting ceremony to formally open the laboratory.
“AppleOne invests in hospitals and facilities, and partners with prestigious companies such as Singapore Diagnostics because we see how important investing in quality healthcare is. This is our way of helping elevate the quality of life of people in Cebu and the VisMin region,” said AppleOne chief executive and president Ray Go Manigsaca.
“By teaming up with VisayasMed Hospital, we’re able to empower and provide Cebuanos with expanded access to a diverse array of top-notch laboratory tests without having the need to travel to Manila or overseas,” said Singapore Diagnostics president Ritche Joseph Manuel Evidente.
The milestone reinforces the group’s commitment to bring in world-class brands and build globally competitive facilities in VisMin and is part of AMG’s strengthened partnership with Singapore Diagnostics (SGD).
SGD will fully operate the laboratory, both inpatient and outpatient, through their well-trained medical technologists and laboratory specialists.
With its groundbreaking collaboration with SGD, VisayasMed Laboratory further elevates healthcare for Cebuanos, now with the capacity to accommodate up to 1,000 patients a day.
It offers 450 cutting-edge tests, global quality laboratory standards, faster results, fully automated operations and specialized training for scientists and medical technologists, heralding a new era of excellence in healthcare.
VisayasMed Hospital, formerly Visayas Community Medical Center, has nearly 70 years of healthcare excellence, delivering top-tier medical services.
SGD is the leading laboratory service provider in the Philippines and the flagship of Pathology Asia, setting global standards. It is the first Philippine laboratory accredited by the College of American Pathologists (CAP).
SGD is a powerhouse in healthcare as it was awarded Diagnostics Provider of the Year by Healthcare Asia twice and was recognized for Service Innovation and Employee Engagement in 2024.
It has over 450 professionals across 47 locations nationwide, processing laboratory tests for over 600 hospitals, clinic labs, and healthcare institutions in the Philippines, and serving up to 100,000 patients every month, SGD is a top player in Philippine laboratories.